Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Sex steroids affect the MafB gene differently in male and female hamsters.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Effective PCOS treatments require targeting specific signaling pathways.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Selecting Angus cattle for earlier puberty lowers prolactin levels but doesn't affect hair growth.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Shift work disrupts the body's natural clock, leading to health problems.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Tph cells are linked to the severity of systemic lupus erythematosus.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Testosterone improves mood and thinking skills; finasteride has no effect.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.